In Reply to Comparison of Measured and Estimated GFR for Rivaroxaban Dosing in Hospitalized Older Adults.

Lyu, Beini; Inker, Lesley A; Shin, Jung-Im

Lyu, Beini; Inker, Lesley A; Shin, Jung-Im.

Afiliación

Lyu B; Institute for Global Health and Development, Peking University, Beijing, China; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland.
Inker LA; Division of Nephrology, Tufts Medical Center, Boston, Massachusetts.
Shin JI; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland; Center for Drug Safety and Effectiveness, Johns Hopkins University, Baltimore, Maryland.

Am J Kidney Dis ; 83(1): 118, 2024 Jan.

Article en En | MEDLINE | ID: mdl-37678742

Asunto(s)

Rivaroxabán; Humanos; Anciano; Rivaroxabán/uso terapéutico; Tasa de Filtración Glomerular

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Rivaroxabán Límite: Aged / Humans Idioma: En Revista: Am J Kidney Dis Año: 2024 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google